NLM logo
5 results
  1. ... Mast-Cell Leukemia, Myeloid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Blast Crisis Leukemia, Myeloid, Accelerated Phase Leukemia, ... Leukemia, Promyelocytic, Acute Leukemia, Myeloid, Chronic, Atypical, ... Acute Leukemia, Myelomonocytic, Chronic Leukemia, Myelomonocytic, ...
  2. ... 557.337.539.250 Leukemia, Myelogenous, Chronic, BCR-ABL Positive C04.557.337.539.250.100 Blast ... 337.539.300 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Nega tive C04.557.337.539.520 Leukemia, ...
  3. ... 557.337.539.250...........................................Leukemia, Myelogenous, Chronic, BCR-ABL Positive C04.557.337.539.250.100...........................................Blast ...
  4. ... ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of ... inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID ...
  5. ... hemagglutinin and neuraminidase activity) ONCOGENE PROTEINS, FUSION BCR-ABL FUSION PROTEINS (translation product of fusion mRNAs) GAG- ... WILMS' TUMOR (PROTO-ONCOGENES) [notnew for 1991] GENES, ABL GENES, FMS GENES, MOS GENES, MIC GENES, SRC ...